HRT misuse and the osteoporosis epidemic

Climacteric

Volumn 15, Issue 1, 2012, Pages 10-11

  Gambacciani, M ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

hormone replacement therapy; Osteoporosis; postmenopause

Indexed keywords

HORMONE;

ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; DRUG MISUSE; EPIDEMIC; FOLLOW UP; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL;

BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HIP FRACTURES; HUMANS; INCIDENCE; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RISK ASSESSMENT; TIME; WITHHOLDING TREATMENT;

EID: 84855229517     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2011.639527     Document Type: Article

References (10)

1. Karim R, Dell RM, Greene DF, Mack WJ, Gallagher JC, Hodis HN. Hip fracture in postmenopausal women after cessation of hormone therapy: Results from a prospective study in a large health management organization. Menopause 2011;18:1172-7
2. Gambacciani M, Ciaponi M, Genazzani AR. The HRT misuse and osteoporosis epidemic: A possible future scenario. Climacteric 2007;10:273-5 (Pubitemid 47123953)
3. Gambacciani M, Genazzani AR. The Xmas present for women's health: A strike to osteoporosis prevention. Maturitas 2004;48: 9-11 (Pubitemid 38829100)
4. Genazzani AR, Gambacciani M, Schneider HP, Christiansen C; International Menopause Society Expert Workshop. Postmenopausal osteoporosis: Therapeutic options. Climacteric 2005;8:99-109
5. Sturdee DW, Pines A, on behalf of the International Menopause Society Writing Group. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302-20
6. Santen RJ, Allred DC, Ardoin SP, e t al Postmenopausal hormone therapy: An Endocrine Society Scientifi c Statement. J Clin Endocrinol Metab 2010;95(Suppl 1):S1-66
7. Lees B, Stevenson JC. The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol- 17 ǎ and dydrogesterone. Osteoporos Int 2001;12:251-8 (Pubitemid 34912730)
8. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. J Am Med Assoc 2002;287:2668-76 (Pubitemid 34533545)
9. Ettinger B, Ensrud KE, Wallace R, e t al Effects of ultralow-dose transdermal estradiol on bone mineral density: A randomized clinical trial. Obstet Gynecol 2004;104:443-51 (Pubitemid 40458828)
10. Lindsay R, Gallagher JC, Kagan R, Pickar JH, Constantine G. Effi cacy of tissue-selective estrogen complex of bazedoxifene/ conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women. Fertil Steril 2009;92:1045-52